The MiSight contact lens was designed by Dr John Phillips and is licensed to CooperVision by the University. It is the first-ever method approved to slow progression of myopia (short-sight) in children. The MiSight lens recently received US Food & Drug Administration (FDA) approval. FDA approval of a product (usually a drug or a device) demonstrates that the product has undergone the rigorous quality evaluation and review of safety and efficacy – in other words, the FDA thinks it is safe and that it works. Obtaining approval in the USA is very significant for two reasons: this allows the lens to be sold in the US, and due to the stringent approval process, other countries which experience high levels of myopia (eg Taiwan) are likely to follow suit in allowing the lens to be distributed.